Neuroscience and Biobehavioral Reviews Cellular and Molecular Neuropathology of the Cuprizone Mouse Model: Clinical Relevance for Multiple Sclerosis
暂无分享,去创建一个
Annemie Van der Linden | Caroline Guglielmetti | Peter Ponsaerts | Jelle Praet | A. Linden | A. Van der Linden | Z. Berneman | J. Praet | C. Guglielmetti | P. Ponsaerts | Zwi Berneman | Jelle Praet | Caroline Guglielmetti
[1] S. Ovsepian,et al. Disruption of Myelin Leads to Ectopic Expression of KV1.1 Channels with Abnormal Conductivity of Optic Nerve Axons in a Cuprizone-Induced Model of Demyelination , 2014, PloS one.
[2] G. Rabinovich,et al. Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination , 2014, Neurobiology of Disease.
[3] D. Ron,et al. PERK activation preserves the viability and function of remyelinating oligodendrocytes in immune-mediated demyelinating diseases. , 2014, The American journal of pathology.
[4] Frederik Maes,et al. Multimodal imaging of subventricular zone neural stem/progenitor cells in the cuprizone mouse model reveals increased neurogenic potential for the olfactory bulb pathway, but no contribution to remyelination of the corpus callosum , 2014, NeuroImage.
[5] Hong-Ju Yang,et al. Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizone , 2014, European Archives of Psychiatry and Clinical Neuroscience.
[6] A. Sawa,et al. Cuprizone short-term exposure: Astrocytic IL-6 activation and behavioral changes relevant to psychosis , 2013, Neurobiology of Disease.
[7] F. Gage,et al. A regenerative approach to the treatment of multiple sclerosis , 2013, Nature.
[8] V. Gallo,et al. SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis , 2013, Glia.
[9] Tatsuhide Tanaka,et al. Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone‐induced demyelination , 2013, Journal of neurochemistry.
[10] Elena V. Klassen,et al. Puma, but not noxa is essential for oligodendroglial cell death , 2013, Glia.
[11] G. Hassanzadeh,et al. Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain. , 2013, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.
[12] H. Basoglu,et al. Cuprizone-induced demyelination in Wistar rats; electrophysiological and histological assessment. , 2013, European review for medical and pharmacological sciences.
[13] M. Selak,et al. Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model , 2013, Journal of Neuroimmunology.
[14] R. Armstrong,et al. FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination , 2013, Neuroscience Letters.
[15] Short-Term Cuprizone Feeding Induces Selective Amino Acid Deprivation with Concomitant Activation of an Integrated Stress Response in Oligodendrocytes , 2013, Cellular and Molecular Neurobiology.
[16] S. Moore,et al. Sex chromosome complement influences functional callosal myelination , 2013, Neuroscience.
[17] K. Kleopa,et al. Alterations of juxtaparanodal domains in two rodent models of CNS demyelination , 2013, Glia.
[18] C. Rapôso,et al. Sildenafil (Viagra) Protective Effects on Neuroinflammation: The Role of iNOS/NO System in an Inflammatory Demyelination Model , 2013, Mediators of inflammation.
[19] Rhusheet P Patel,et al. Attenuation of Corpus Callosum Axon Myelination and Remyelination in the Absence of Circulating Sex Hormones , 2013, Brain pathology.
[20] J. Maeda,et al. Loss of Branched O-Mannosyl Glycans in Astrocytes Accelerates Remyelination , 2013, The Journal of Neuroscience.
[21] V. Baekelandt,et al. Local Overexpression of Interleukin-11 in the Central Nervous System Limits Demyelination and Enhances Remyelination , 2013, Mediators of inflammation.
[22] TRO19622 promotes myelin repair in a rat model of demyelination , 2013, The International journal of neuroscience.
[23] Cuprizone-Induced Demyelination as a Tool to Study Remyelination and Axonal Protection , 2013, Journal of Molecular Neuroscience.
[24] Cheng He,et al. A functional role of NMDA receptor in regulating the differentiation of oligodendrocyte precursor cells and remyelination , 2013, Glia.
[25] T. Kilpatrick,et al. Investigation of Sequential Growth Factor Delivery during Cuprizone Challenge in Mice Aimed to Enhance Oligodendrogliogenesis and Myelin Repair , 2013, PloS one.
[26] B. Trapp,et al. Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR‐124 and reduced AMPA receptors , 2013, Annals of neurology.
[27] Chengren Li,et al. Cuprizone-induced demyelination in mice: age-related vulnerability and exploratory behavior deficit , 2013, Neuroscience Bulletin.
[28] G. Matsushima,et al. Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte loss , 2013, Journal of neuroscience research.
[29] J. Boggs,et al. G protein‐coupled receptor 30 contributes to improved remyelination after cuprizone‐induced demyelination , 2013, Glia.
[30] Vikramjeet Singh,et al. Cuprizone [Bis(Cyclohexylidenehydrazide)] is Selectively Toxic for Mature Oligodendrocytes , 2013, Neurotoxicity Research.
[31] Yan Xu,et al. Progesterone Alleviates Neural Behavioral Deficits and Demyelination with Reduced Degeneration of Oligodendroglial Cells in Cuprizone-Induced Mice , 2013, PloS one.
[32] W. Baumgärtner,et al. Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination. , 2013, Brain : a journal of neurology.
[33] Bartosz Bielecki,et al. The neural androgen receptor: a therapeutic target for myelin repair in chronic demyelination. , 2013, Brain : a journal of neurology.
[34] R. Armstrong,et al. Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination , 2012, ASN neuro.
[35] A. Chédotal,et al. Role of transmembrane semaphorin Sema6A in oligodendrocyte differentiation and myelination , 2012, Glia.
[36] D. Pleasure,et al. Interferon regulatory factor 8/interferon consensus sequence binding protein is a critical transcription factor for the physiological phenotype of microglia , 2012, Journal of Neuroinflammation.
[37] L. P. Chen,et al. Regulation of Olig2 during astroglial differentiation in the subventricular zone of a cuprizone-induced demyelination mouse model , 2012, Neuroscience.
[38] R. Klein,et al. Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS , 2012, Acta Neuropathologica.
[39] S. Komoly,et al. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination. , 2012, Ideggyogyaszati szemle.
[40] P. Paez,et al. Golli myelin basic proteins stimulate oligodendrocyte progenitor cell proliferation and differentiation in remyelinating adult mouse brain , 2012, Glia.
[41] R. Ransohoff,et al. IL-17-Induced Act1-Mediated Signaling Is Critical for Cuprizone-Induced Demyelination , 2012, The Journal of Neuroscience.
[42] J. Frahm,et al. Erythropoietin Attenuates Neurological and Histological Consequences of Toxic Demyelination in Mice , 2012, Molecular Medicine.
[43] J. Pasquini,et al. Cuprizone-induced demyelination in the rat cerebral cortex and thyroid hormone effects on cortical remyelination , 2012, Experimental Neurology.
[44] B. Barres,et al. The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration , 2012, Molecular and Cellular Neuroscience.
[45] F. Bosetti,et al. The cyclooxygenase‐2 pathway via the PGE2 EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone‐induced demyelination , 2012, Journal of neurochemistry.
[46] Ralph Sinkus,et al. Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography , 2012, Proceedings of the National Academy of Sciences.
[47] J. Kong,et al. Galanin Transgenic Mice with Elevated Circulating Galanin Levels Alleviate Demyelination in a Cuprizone-Induced MS Mouse Model , 2012, PloS one.
[48] R. König,et al. Expression of retinoid X receptor beta is induced in astrocytes during corpus callosum demyelination , 2012, Journal of Chemical Neuroanatomy.
[49] S. Mori,et al. In vivo and ex vivo diffusion tensor imaging of cuprizone‐induced demyelination in the mouse corpus callosum , 2012, Magnetic resonance in medicine.
[50] D. Mahad,et al. Mitochondrial changes associated with demyelination: consequences for axonal integrity. , 2012, Mitochondrion.
[51] N. Yamada,et al. Hexachlorophene and cuprizone induce the spongy change of the developing rat brain by different mechanisms: the role of 2', 3'-cyclic nucleotide 3'-phosphodiesterase (CNPase). , 2012, The Journal of veterinary medical science.
[52] W. Brück,et al. Late motor decline after accomplished remyelination: Impact for progressive multiple sclerosis , 2012, Annals of neurology.
[53] M. Olah,et al. Identification of a microglia phenotype supportive of remyelination , 2012, Glia.
[54] C. Trebst,et al. Characterisation of microglia during de- and remyelination: Can they create a repair promoting environment? , 2012, Neurobiology of Disease.
[55] L. Pasquini,et al. Adult CNP::EGFP transgenic mouse shows pronounced hypomyelination and an increased vulnerability to cuprizone-induced demyelination , 2012, Experimental Neurology.
[56] R. Armstrong,et al. Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination , 2012, Neurobiology of Disease.
[57] M. Day,et al. Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice , 2012, Neuroscience.
[58] H. Kinney,et al. Aberrant Upregulation of Astroglial Ceramide Potentiates Oligodendrocyte Injury , 2012, Brain pathology.
[59] Martin Stangel,et al. De- and remyelination in the CNS white and grey matter induced by cuprizone: the old, the new, and the unexpected. , 2011, Histology and histopathology.
[60] F. Zipp,et al. BLBP-expression in astrocytes during experimental demyelination and in human multiple sclerosis lesions , 2011, Brain, Behavior, and Immunity.
[61] C. Trebst,et al. Lipopolysaccharide delays demyelination and promotes oligodendrocyte precursor proliferation in the central nervous system , 2011, Brain, Behavior, and Immunity.
[62] J. Bol,et al. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin‐forming oligodendrocytes during CNS remyelination , 2011, Glia.
[63] G. Rabinovich,et al. Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function , 2011, Cell Death and Differentiation.
[64] C. Dreyfus,et al. Levels of BDNF Impact Oligodendrocyte Lineage Cells following a Cuprizone Lesion , 2011, The Journal of Neuroscience.
[65] K. Guckian,et al. Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo , 2011, Molecular and Cellular Neuroscience.
[66] W. Baumgärtner,et al. Matrix Metalloproteinases and Their Tissue Inhibitors in Cuprizone-Induced Demyelination and Remyelination of Brain White and Gray Matter , 2011, Journal of neuropathology and experimental neurology.
[67] M. Stangel,et al. Spatial and Temporal Profiles of Growth Factor Expression during CNS Demyelination Reveal the Dynamics of Repair Priming , 2011, PloS one.
[68] F. Bosetti,et al. Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.
[69] F. Bosetti,et al. Inhibition of 5-lipoxygenase activity in mice during cuprizone-induced demyelination attenuates neuroinflammation, motor dysfunction and axonal damage. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.
[70] C. Beyer,et al. Corticosteroids Impair Remyelination in the Corpus Callosum of Cuprizone‐Treated Mice , 2011, Journal of neuroendocrinology.
[71] Haiyun Xu,et al. Recovery of Behavioral Changes and Compromised White Matter in C57BL/6 Mice Exposed to Cuprizone: Effects of Antipsychotic Drugs , 2011, Front. Behav. Neurosci..
[72] W. Deng,et al. Zfp488 promotes oligodendrocyte differentiation of neural progenitor cells in adult mice after demyelination , 2011, Scientific reports.
[73] David M Frim,et al. Olig1 is expressed in human oligodendrocytes during maturation and regeneration , 2011, Glia.
[74] S. Ludwin,et al. Neurobiological effects of sphingosine 1‐phosphate receptor modulation in the cuprizone model , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[75] M. Grégoire,et al. Evaluation of [123I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[76] T. Kilpatrick,et al. Remyelination Is Altered by Bone Morphogenic Protein Signaling in Demyelinated Lesions , 2011, The Journal of Neuroscience.
[77] Junhua Xiao,et al. Gas6 Increases Myelination by Oligodendrocytes and Its Deficiency Delays Recovery following Cuprizone-Induced Demyelination , 2011, PloS one.
[78] A. Mildner,et al. IkappaB kinase 2 determines oligodendrocyte loss by non-cell-autonomous activation of NF-kappaB in the central nervous system. , 2011, Brain : a journal of neurology.
[79] Sheng-Kwei Song,et al. Reduced Axonopathy and Enhanced Remyelination After Chronic Demyelination in Fibroblast Growth Factor 2 (Fgf2)-Null Mice: Differential Detection With Diffusion Tensor Imaging , 2011, Journal of neuropathology and experimental neurology.
[80] C. Konradi,et al. Myelin, copper, and the cuprizone model of schizophrenia. , 2011, Frontiers in bioscience.
[81] Xiaosong Li,et al. GAS6 Enhances Repair Following Cuprizone-Induced Demyelination , 2010, PloS one.
[82] N. Scolding,et al. Mechanisms of Oxidative Damage in Multiple Sclerosis and a Cell Therapy Approach to Treatment , 2010, Autoimmune diseases.
[83] H. Hildebrandt,et al. Remyelination after cuprizone induced demyelination is accelerated in mice deficient in the polysialic acid synthesizing enzyme St8siaIV , 2010, Neuroscience.
[84] Denis Gris,et al. The Inflammasome Sensor, NLRP3, Regulates CNS Inflammation and Demyelination via Caspase-1 and Interleukin-18 , 2010, The Journal of Neuroscience.
[85] S. Barnum,et al. CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model. , 2010, Molecular immunology.
[86] G. Egan,et al. Influence of methylprednisolone on magnetic resonance and histological measures during cuprizone-induced demyelination , 2010, Neuroscience Letters.
[87] R. Parenti,et al. Dynamic expression of Cx47 in mouse brain development and in the cuprizone model of myelin plasticity , 2010, Glia.
[88] T. Kilpatrick,et al. Modulation of bone morphogenic protein signalling alters numbers of astrocytes and oligodendroglia in the subventricular zone during cuprizone‐induced demyelination , 2010, Journal of neurochemistry.
[89] S. Mammi,et al. Cuprizone neurotoxicity, copper deficiency and neurodegeneration. , 2010, Neurotoxicology.
[90] J. Ting,et al. 17β-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss , 2010, Neurobiology of Disease.
[91] O. Elroy-Stein,et al. A mouse model for eukaryotic translation initiation factor 2B-leucodystrophy reveals abnormal development of brain white matter. , 2010, Brain : a journal of neurology.
[92] R. Ransohoff,et al. Myelin Repair Is Accelerated by Inactivating CXCR2 on Nonhematopoietic Cells , 2010, The Journal of Neuroscience.
[93] Eduardo Soto,et al. Cuprizone‐induced demyelination in CNP::GFP transgenic mice , 2010, The Journal of comparative neurology.
[94] C. Trebst,et al. Beneficial Effects of Minocycline on Cuprizone Induced Cortical Demyelination , 2010, Neurochemical Research.
[95] R. Klein,et al. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination , 2010, Proceedings of the National Academy of Sciences.
[96] T. Pufe,et al. ADAM12 is expressed by astrocytes during experimental demyelination , 2010, Brain Research.
[97] R. Ransohoff,et al. CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis , 2010, Nature Neuroscience.
[98] Z. Berente,et al. Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death. , 2010, Brain : a journal of neurology.
[99] J. Ting,et al. Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle , 2010, Journal of neuroscience research.
[100] R. Browning,et al. Behavioral and Neurobiological Changes in C57BL/6 Mouse Exposed to Cuprizone: Effects of Antipsychotics , 2010, Front. Behav. Neurosci..
[101] Richard Reynolds,et al. HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage , 2009, Nature Neuroscience.
[102] W. Brück,et al. In toxic demyelination oligodendroglial cell death occurs early and is FAS independent , 2009, Neurobiology of Disease.
[103] D. Crawford,et al. Functional recovery of callosal axons following demyelination: a critical window , 2009, Neuroscience.
[104] C. Beyer,et al. Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia , 2009, Brain Research.
[105] Sjef Copray,et al. The cuprizone animal model: new insights into an old story , 2009, Acta Neuropathologica.
[106] C. Konradi,et al. Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats , 2009, Schizophrenia Research.
[107] Takahira Yamauchi,et al. Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[108] Martin Stangel,et al. Regional differences between grey and white matter in cuprizone induced demyelination , 2009, Brain Research.
[109] W. Paulus,et al. Cuprizone demyelination of the corpus callosum in mice correlates with altered social interaction and impaired bilateral sensorimotor coordination , 2009, ASN neuro.
[110] Z. Berente,et al. 17β‐estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice , 2009, Glia.
[111] C. Moiola,et al. Partial inhibition of proteasome activity enhances remyelination after cuprizone-induced demyelination , 2009, Experimental Neurology.
[112] Diego G. Silva,et al. Demyelination caused by the copper chelator cuprizone halts T cell mediated autoimmune neuroinflammation , 2009, Journal of Neuroimmunology.
[113] S. Johann,et al. Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus , 2009, Journal of neuroscience research.
[114] S. Ludwin,et al. Statin therapy inhibits remyelination in the central nervous system. , 2009, The American journal of pathology.
[115] Richard Clough,et al. Behavioral and neurobiological changes in C57BL/6 mice exposed to cuprizone. , 2009, Behavioral neuroscience.
[116] W. Brück,et al. Type I interferon receptor signalling is induced during demyelination while its function for myelin damage and repair is redundant , 2009, Experimental Neurology.
[117] A. Wanaka,et al. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions , 2009, Neurochemistry International.
[118] A. Chédotal,et al. Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells , 2009, Annals of neurology.
[119] J. Stankiewicz,et al. Role of iron in neurotoxicity: a cause for concern in the elderly? , 2009, Current opinion in clinical nutrition and metabolic care.
[120] H. Neumann,et al. Debris clearance by microglia: an essential link between degeneration and regeneration , 2008, Brain : a journal of neurology.
[121] Patrick Poulet,et al. Recovery from Chronic Demyelination by Thyroid Hormone Therapy: Myelinogenesis Induction and Assessment by Diffusion Tensor Magnetic Resonance Imaging , 2008, The Journal of Neuroscience.
[122] R. Hider,et al. Iron chelation as a potential therapy for neurodegenerative disease. , 2008, Biochemical Society transactions.
[123] Haiyun Xu,et al. Quetiapine alleviates the cuprizone-induced white matter pathology in the brain of C57BL/6 mouse , 2008, Schizophrenia Research.
[124] C. Lawless,et al. Mitochondrial turnover in liver is fast in vivo and is accelerated by dietary restriction: application of a simple dynamic model , 2008, Aging cell.
[125] C. Brosnan,et al. Axl−/− mice have delayed recovery and prolonged axonal damage following cuprizone toxicity , 2008, Brain Research.
[126] K. Takakusaki,et al. Differential changes in axonal conduction following CNS demyelination in two mouse models , 2008, The European journal of neuroscience.
[127] J. Ting,et al. MHC class II exacerbates demyelination in vivo independently of T cells , 2008, Journal of Neuroimmunology.
[128] T. Abel,et al. Low sociability is associated with reduced size of the corpus callosum in the BALB/cJ inbred mouse strain , 2008, Brain Research.
[129] Oded Gonen,et al. Monitoring demyelination and remyelination by magnetization transfer imaging in the mouse brain at 9.4 T , 2008, Magnetic Resonance Materials in Physics, Biology and Medicine.
[130] R. Franklin,et al. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency , 2008, Nature Neuroscience.
[131] J. Pasquini,et al. Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination , 2008, Experimental Neurology.
[132] C. Trebst,et al. The chemokine receptor CXCR2 is differentially regulated on glial cells in vivo but is not required for successful remyelination after cuprizone‐induced demyelination , 2008, Glia.
[133] S. Kumar,et al. Activation of Inflammatory Response by a Combination of Growth Factors in Cuprizone-Induced Demyelinated Brain Leads to Myelin Repair , 2008, Neurochemical Research.
[134] Jin Young Kim,et al. Inhibition of p53 Transcriptional Activity: A Potential Target for Future Development of Therapeutic Strategies for Primary Demyelination , 2008, The Journal of Neuroscience.
[135] K. Irvine,et al. Remyelination protects axons from demyelination-associated axon degeneration. , 2008, Brain : a journal of neurology.
[136] Hans Lassmann,et al. Mitochondrial defects in acute multiple sclerosis lesions , 2008, Brain : a journal of neurology.
[137] H. Mehmet,et al. Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease , 2008, Cell Death and Differentiation.
[138] P. Carmeliet,et al. Gas6 Deficiency Increases Oligodendrocyte Loss and Microglial Activation in Response to Cuprizone-Induced Demyelination , 2008, The Journal of Neuroscience.
[139] G. Egan,et al. Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair , 2008, Glia.
[140] Wolfgang Löscher,et al. Epileptic seizures and hippocampal damage after cuprizone-induced demyelination in C57BL/6 mice , 2008, Experimental Neurology.
[141] Qing Yang,et al. MRI identification of the rostral‐caudal pattern of pathology within the corpus callosum in the cuprizone mouse model , 2008, Journal of magnetic resonance imaging : JMRI.
[142] Blakemore Wf,et al. Endogenous or exogenous oligodendrocytes for remyelination. , 2008 .
[143] H. Iocca,et al. TNF superfamily member TWEAK exacerbates inflammation and demyelination in the cuprizone-induced model , 2008, Journal of Neuroimmunology.
[144] Si-young Song,et al. Expression of an acyl‐CoA synthetase, lipidosin, in astrocytes of the murine brain and its up‐regulation during remyelination following cuprizone‐induced demyelination , 2007, Journal of neuroscience research.
[145] R. Kaufman,et al. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? , 2007, Antioxidants & redox signaling.
[146] S. Barnum,et al. Astrocyte‐specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model , 2007, Glia.
[147] R. Armstrong,et al. Platelet-Derived Growth Factor Promotes Repair of Chronically Demyelinated White Matter , 2007, Journal of neuropathology and experimental neurology.
[148] W. Baumgärtner,et al. Lack of interferon-beta leads to accelerated remyelination in a toxic model of central nervous system demyelination , 2007, Acta Neuropathologica.
[149] M. Carson,et al. Lymphotoxin β Receptor (LtβR): Dual Roles in Demyelination and Remyelination and Successful Therapeutic Intervention Using LtβR–Ig Protein , 2007, The Journal of Neuroscience.
[150] L. Vallières,et al. Identification of genes preferentially expressed by microglia and upregulated during cuprizone‐induced inflammation , 2007, Glia.
[151] A. Casini,et al. Unravelling the chemical nature of copper cuprizone. , 2007, Dalton transactions.
[152] T. Owens,et al. Microglial recruitment, activation, and proliferation in response to primary demyelination. , 2007, The American journal of pathology.
[153] T. Ueki,et al. Restoration of FcRγ/Fyn signaling repairs central nervous system demyelination , 2007, Neuroscience Research.
[154] E. Vilella,et al. Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelination. , 2007, Toxicology letters.
[155] T. Yagi,et al. Restoration of FcRgamma/Fyn signaling repairs central nervous system demyelination. , 2007, Journal of neuroscience research.
[156] M. Carson,et al. Lymphotoxin beta receptor (Lt betaR): dual roles in demyelination and remyelination and successful therapeutic intervention using Lt betaR-Ig protein. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[157] S. Kumar,et al. Combination of Growth Factors Enhances Remyelination in a Cuprizone-induced Demyelination Mouse Model , 2007, Neurochemical Research.
[158] L. Pasquini,et al. The Neurotoxic Effect of Cuprizone on Oligodendrocytes Depends on the Presence of Pro-inflammatory Cytokines Secreted by Microglia , 2007, Neurochemical Research.
[159] D. Willenborg,et al. Neuronal Nitric Oxide Synthase Plays a Key Role in CNS Demyelination , 2006, The Journal of Neuroscience.
[160] D. Liebetanz,et al. Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis , 2006, Experimental Neurology.
[161] Y. J. Kang. Metallothionein Redox Cycle and Function , 2006, Experimental biology and medicine.
[162] G. Almazan,et al. Iron contributes to dopamine‐induced toxicity in oligodendrocyte progenitors , 2006, Neuropathology and applied neurobiology.
[163] A. Schousboe,et al. The glutamate/GABA‐glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer , 2006, Journal of neurochemistry.
[164] W. F. Blakemore,et al. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice , 2006, Journal of Neuroimmunology.
[165] R. Kothary,et al. Dominant‐negative β1 integrin mice have region‐specific myelin defects accompanied by alterations in MAPK activity , 2006, Glia.
[166] T. Guilarte,et al. Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination. , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[167] T. Kilpatrick,et al. Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[168] D. Ron,et al. Interferon-γ inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress , 2006 .
[169] D. Willenborg,et al. Deleterious role of IFNgamma in a toxic model of central nervous system demyelination. , 2006, The American journal of pathology.
[170] P. Paez,et al. Remyelination after cuprizone-induced demyelination in the rat is stimulated by apotransferrin , 2006, Experimental Neurology.
[171] M. Carson,et al. Upregulation of the stress‐associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues , 2006, Glia.
[172] R. Armstrong,et al. Endogenous Cell Repair of Chronic Demyelination , 2006, Journal of neuropathology and experimental neurology.
[173] Hsiao-Fang Liang,et al. Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum , 2006, Magnetic resonance in medicine.
[174] Chao Zhao,et al. Myelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation , 2006, The Journal of Neuroscience.
[175] W. Cammer,et al. Expression of carbonic anhydrase II mRNA and protein in oligodendrocytes during toxic demyelination in the young adult mouse , 1996, Neurochemical Research.
[176] D. Ron,et al. Interferon-gamma inhibits central nervous system remyelination through a process modulated by endoplasmic reticulum stress. , 2006, Brain : a journal of neurology.
[177] H. Boddeke,et al. p75NTR independent oligodendrocyte death in cuprizone‐induced demyelination in C57BL/6 mice , 2005, Neuropathology and applied neurobiology.
[178] John Calvin Reed,et al. Endoplasmic reticulum stress: cell life and death decisions. , 2005, The Journal of clinical investigation.
[179] Jens Frahm,et al. Multicontrast MRI of remyelination in the central nervous system , 2005, NMR in biomedicine.
[180] Petti T. Pang,et al. The yin and yang of neurotrophin action , 2005, Nature Reviews Neuroscience.
[181] W. Wittkowski,et al. Copper and zinc dismetabolism in the mouse brain upon chronic cuprizone treatment , 2005, Cellular and Molecular Life Sciences CMLS.
[182] R. Armstrong,et al. PDGF and FGF2 pathways regulate distinct oligodendrocyte lineage responses in experimental demyelination with spontaneous remyelination , 2005, Neurobiology of Disease.
[183] Jun Yoshino,et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain , 2005, NeuroImage.
[184] S. Komoly. Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected]. , 2005, Ideggyogyaszati szemle.
[185] M. Subramanian,et al. Effect of cuprizone feeding on hepatic superoxide dismutase and cytochrome oxidase activities in mice , 1982, Experientia.
[186] H. Arnett,et al. Astroglial‐derived lymphotoxin‐α exacerbates inflammation and demyelination, but not remyelination , 2005, Glia.
[187] E. Mandelkow,et al. Hyperphosphorylation and Aggregation of Tau in Experimental Autoimmune Encephalomyelitis* , 2004, Journal of Biological Chemistry.
[188] D. Rowitch,et al. bHLH Transcription Factor Olig1 Is Required to Repair Demyelinated Lesions in the CNS , 2004, Science.
[189] Trevor J Kilpatrick,et al. Expression of the low‐affinity neurotrophin receptor, p75NTR, is upregulated by oligodendroglial progenitors adjacent to the subventricular zone in response to demyelination , 2004, Glia.
[190] Olivier Yu,et al. Remyelination assessment by MRI texture analysis in a cuprizone mouse model. , 2004, Magnetic resonance imaging.
[191] U. Suter,et al. Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. , 2004, Brain : a journal of neurology.
[192] B. Popko,et al. Oligodendrocytes assist in the maintenance of sodium channel clusters independent of the myelin sheath. , 2004, Neuron glia biology.
[193] Á. Hermida-Ameijeiras,et al. Autoxidation and MAO-mediated metabolism of dopamine as a potential cause of oxidative stress: role of ferrous and ferric ions , 2004, Neurochemistry International.
[194] S. Levison,et al. Pro‐regenerative properties of cytokine‐activated astrocytes , 2004, Journal of neurochemistry.
[195] T. Guilarte,et al. Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization. , 2004, Brain : a journal of neurology.
[196] J. Goldman,et al. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. , 2004, The American journal of pathology.
[197] U. Boschert,et al. Osteopontin is upregulated during in vivo demyelination and remyelination and enhances myelin formation in vitro , 2004, Molecular and Cellular Neuroscience.
[198] G. Rotilio,et al. Mitochondrial Dysfunction in Neurodegenerative Diseases Associated with Copper Imbalance , 2004, Neurochemical Research.
[199] W. Richardson,et al. Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination , 2004, Molecular and Cellular Neuroscience.
[200] Santa Jeremy Ono,et al. A CIITA‐independent pathway that promotes expression of endogenous rather than exogenous peptides in immune‐privileged sites , 2004, European journal of immunology.
[201] E. M. Carey,et al. Biochemical changes in cuprizone-induced spongiform encephalopathy , 1983, Neurochemical Research.
[202] S. Ludwin,et al. An immunohistochemical study of myelin proteins during remyelination in the central nervous system , 2004, Acta Neuropathologica.
[203] J. Ting,et al. Functional Genomic Analysis of Remyelination Reveals Importance of Inflammation in Oligodendrocyte Regeneration , 2003, The Journal of Neuroscience.
[204] Ueli Suter,et al. Quantifying the Early Stages of Remyelination Following Cuprizone‐induced Demyelination , 2003, Brain pathology.
[205] P. Paez,et al. Inhibition of the Proteasome by Lactacystin Enhances Oligodendroglial Cell Differentiation , 2003, The Journal of Neuroscience.
[206] G. Levi,et al. Differential Lipid Peroxidation, Mn Superoxide, and bcl‐2 Expression Contribute to the Maturation‐Dependent Vulnerability of Oligodendrocytes to Oxidative Stress , 2003, Journal of neuropathology and experimental neurology.
[207] M. Goldberg,et al. Oligodendrocytes and Ischemic Brain Injury , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[208] K. Jellinger,et al. Preferential Loss of Myelin‐Associated Glycoprotein Reflects Hypoxia‐Like White Matter Damage in Stroke and Inflammatory Brain Diseases , 2003, Journal of neuropathology and experimental neurology.
[209] B. Juurlink,et al. Differential vulnerability of oligodendrocytes and astrocytes to hypoxic–ischemic stresses , 2003 .
[210] T. Wakabayashi. Megamitochondria formation ‐ physiology and pathology , 2002, Journal of cellular and molecular medicine.
[211] R. Armstrong,et al. Absence of Fibroblast Growth Factor 2 Promotes Oligodendroglial Repopulation of Demyelinated White Matter , 2002, The Journal of Neuroscience.
[212] G. Matsushima,et al. Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood–brain barrier , 2002, Journal of Neuroimmunology.
[213] D. Sammond,et al. Alterations in metabolism and gene expression in brain regions during cuprizone‐induced demyelination and remyelination , 2002, Journal of neurochemistry.
[214] P. Sanberg,et al. Neuroscience and Biobehavioral Reviews , 2002, Physiology & Behavior.
[215] J. Ting,et al. The Protective Role of Nitric Oxide in a Neurotoxicant- Induced Demyelinating Model1 , 2002, The Journal of Immunology.
[216] J. Ting,et al. TNFα promotes proliferation of oligodendrocyte progenitors and remyelination , 2001, Nature Neuroscience.
[217] M. Ruberg,et al. Noradrenaline provides long‐term protection to dopaminergic neurons by reducing oxidative stress , 2001, Journal of neurochemistry.
[218] D. Chaplin,et al. Interleukin-1β Promotes Repair of the CNS , 2001, The Journal of Neuroscience.
[219] D. Cook,et al. Absence of Macrophage-Inflammatory Protein-1α Delays Central Nervous System Demyelination in the Presence of an Intact Blood-Brain Barrier1 , 2001, The Journal of Immunology.
[220] L. Horrocks,et al. Book Review: Plasmalogens: Workhorse Lipids of Membranes in Normal and Injured Neurons and Glia , 2001 .
[221] D. Sammond,et al. Cerebroside synthesis as a measure of the rate of remyelination following cuprizone‐induced demyelination in brain , 2001, Journal of neurochemistry.
[222] N. Baumann,et al. Biology of oligodendrocyte and myelin in the mammalian central nervous system. , 2001, Physiological reviews.
[223] K Suzuki,et al. Episodic demyelination and subsequent remyelination within the murine central nervous system: changes in axonal calibre , 2001, Neuropathology and applied neurobiology.
[224] P. Morell,et al. The Neurotoxicant, Cuprizone, as a Model to Study Demyelination and Remyelination in the Central Nervous System , 2001, Brain pathology.
[225] K Suzuki,et al. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. , 2001, Nature neuroscience.
[226] D. Chaplin,et al. Interleukin-1beta promotes repair of the CNS. , 2001, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[227] L. Horrocks,et al. Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia. , 2001, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.
[228] P. Ye,et al. Interferon-γ Protects against Cuprizone-Induced Demyelination , 2000, Molecular and Cellular Neuroscience.
[229] M. Taniike,et al. Mature oligodendrocyte apoptosis precedes IGF‐1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination , 2000, Journal of neuroscience research.
[230] P. Ye,et al. Insulin-Like Growth Factor-1 Inhibits Mature Oligodendrocyte Apoptosis during Primary Demyelination , 2000, The Journal of Neuroscience.
[231] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[232] P. Ye,et al. Interferon-gamma protects against cuprizone-induced demyelination. , 2000, Molecular and cellular neurosciences.
[233] W. Cammer. The neurotoxicant, cuprizone, retards the differentiation of oligodendrocytes in vitro , 1999, Journal of the Neurological Sciences.
[234] K. Suzuki,et al. Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice , 1998, Journal of Neuroimmunology.
[235] A. Lees,et al. Conjugates of Catecholamines with Cysteine and GSH in Parkinson's Disease: Possible Mechanisms of Formation Involving Reactive Oxygen Species , 1998, Journal of neurochemistry.
[236] P. Morell,et al. Gene Expression in Brain during Cuprizone-Induced Demyelination and Remyelination , 1998, Molecular and Cellular Neuroscience.
[237] L. Hertz,et al. Peroxide‐scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress , 1998, Glia.
[238] A. Consiglio,et al. Tumor necrosis factor α and its receptors in relapsing-remitting multiple sclerosis , 1997, Journal of the Neurological Sciences.
[239] H. Zhang,et al. Rapid upregulation of the Pi isoform of glutathione-S-transferase in mouse brains after withdrawal of the neurotoxicant, cuprizone. , 1997, Molecular and chemical neuropathology.
[240] B. Trapp,et al. Differentiation and Death of Premyelinating Oligodendrocytes in Developing Rodent Brain , 1997, The Journal of cell biology.
[241] H. Lassmann,et al. TNF-α receptor fusion protein prevents experimental auto-immune encephalomyelitis and demyelination in Lewis rats: an overview , 1997, Journal of Neuroimmunology.
[242] A. Consiglio,et al. Tumor necrosis factor alpha and its receptors in relapsing-remitting multiple sclerosis. , 1997, Journal of the neurological sciences.
[243] H. Zhang,et al. Atypical localization of the oligodendrocytic isoform (PI) of glutathione‐S‐transferase in astrocytes during cuprizone intoxication , 1993, Journal of neuroscience research.
[244] H. Webster,et al. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[245] M. Zoratti,et al. A characterization of cuprizone-induced giant mouse liver mitochondria , 1990, Journal of bioenergetics and biomembranes.
[246] S. Love,et al. Cuprizone neurotoxicity in the rat: Morphologic observations , 1988, Journal of the Neurological Sciences.
[247] S. Ludwin,et al. Blood-brain barrier permeability during Cuprizone-induced demyelination Implications for the pathogenesis of immune-mediated demyelinating diseases , 1987, Journal of the Neurological Sciences.
[248] D. Gospodarowicz,et al. Fibroblast growth factor , 1986, Molecular and Cellular Endocrinology.
[249] Russanov Em,et al. Differences in the in vivo effects of cuprizone on superoxide dismutase activity in rat liver cytosol and mitochondrial intermembrane space. , 1985 .
[250] E. Russanov,et al. Differences in the in vivo effects of cuprizone on superoxide dismutase activity in rat liver cytosol and mitochondrial intermembrane space. , 1985, Acta physiologica et pharmacologica Bulgarica.
[251] Blakemore Wf. The response of oligodendrocytes to chemical injury. , 1984 .
[252] W. Blakemore. The response of oligodendrocytes to chemical injury. , 1984, Acta neurologica Scandinavica. Supplementum.
[253] K. Famulski,et al. Changes in the mitochondrial surface potential during cuprizone-induced formation of megamitochondria. , 1982, European Journal of Cell Biology.
[254] T. Flatmark,et al. Induction of megamitochondria by cuprizone(biscyclohexanone oxaldihydrazone). Evidence for an inhibition of the mitochondrial division process. , 1980, European journal of cell biology.
[255] Ludwin Sk. Chronic demyelination inhibits remyelination in the central nervous system. An analysis of contributing factors. , 1980 .
[256] E. Russanov,et al. Effect of cuprizone on copper exchange and superoxide dismutase activity in rat liver. , 1980, General pharmacology.
[257] S. Ludwin. Chronic demyelination inhibits remyelination in the central nervous system. An analysis of contributing factors. , 1980, Laboratory investigation; a journal of technical methods and pathology.
[258] Ludwin Sk. Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. , 1978 .
[259] H. Kishimoto,et al. MECHANISM OF THE FORMATION OF MEGAMITOCHONDRIA BY COPPER‐CHELATING AGENTS V. FURTHER STUDIES ON ISOLATED MEGAMITOCHONDRIA , 1978, Acta pathologica japonica.
[260] H. Kishimoto,et al. MECHANISM OF THE FORMATION OF MEGAMITOCHONDRIA BY COPPER‐CHELATING AGENTS IV. ROLE OF FUSION PHENOMENON IN THE CUPRIZONE‐INDUCED MEGAMITOCHONDRIAL FORMATION , 1978, Acta pathologica japonica.
[261] S. Ludwin. Central nervous system demyelination and remyelination in the mouse: an ultrastructural study of cuprizone toxicity. , 1978, Laboratory investigation; a journal of technical methods and pathology.
[262] J. Rafael,et al. Biochemical properties of liver megamitochondria induced by chloramphenicol or cuprizone. , 1977, Experimental cell research.
[263] H. Kishimoto,et al. Cuprizone-induced megamitochondrial formation and membrane fusion. , 1977, Journal of electron microscopy.
[264] R. Kimberlin,et al. Profiles of brain glycosidase activity in cuprizone-fed Syrian hamsters and in scrapie-affected mice, rats, Chinese hamsters and Syrian hamsters. , 1976, Journal of comparative pathology.
[265] T. Ozawa,et al. MECHANISM OF THE FORMATION OF MEGAMITOCHONDRIA INDUCED BY COPPER‐CHELATING AGENTS , 1975, Acta pathologica japonica.
[266] C. Kurono,et al. Mechanism of the formation of megamitochondria induced by copper-chelating agents. II. Isolation and some properties of megamitochondria from the cuprizone-treated mouse liver. , 1975, Acta pathologica japonica.
[267] C. Hoppel,et al. The failure of supplemental dietary copper to prevent cuprizone-induced alterations in mouse hepatocytes. , 1975, Beitrage zur Pathologie.
[268] G Venturini,et al. ENZYMIC ACTIVITIES AND SODIUM, POTASSIUM AND COPPER CONCENTRATIONS IN MOUSE BRAIN AND LIVER AFTER CUPRIZONE TREATMENT IN VIVO , 1973, Journal of neurochemistry.
[269] B. Sansom,et al. Permeability of blood vessels in mice affected with scrapie or fed with cuprizone. , 1973, Journal of comparative pathology.
[270] W. Blakemore. Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. , 1973, Journal of the neurological sciences.
[271] J. Howell,et al. Variation in the response of mice to cuprizone. , 1973, Research in veterinary science.
[272] C. Hoppel,et al. DIVISION OF GIANT MITOCHONDRIA DURING RECOVERY FROM CUPRIZONE INTOXICATION , 1973, The Journal of cell biology.
[273] W. Blakemore. Observations on oligodendrocyte degeneration, the resolution of status spongiosus and remyelination in cuprizone intoxication in mice , 1972, Journal of neurocytology.
[274] W. Carlton,et al. Cuprizone toxicosis in mice--attempts to antidote the toxicity. , 1972, Toxicology and applied pharmacology.
[275] W. Carlton,et al. Histopathologic and enzyme histochemical observations of the cuprizone-induced brain edema. , 1971, Experimental and molecular pathology.
[276] I. Pattison,et al. Clinical and histological observations on cuprizone toxicity and scrapie in mice. , 1971, Research in veterinary science.
[277] W. Carlton,et al. Ultrastructural changes of cuprizone encephalopathy in mice. , 1971, Toxicology and applied pharmacology.
[278] W. Carlton,et al. Aqueductal stenosis as the cause of hydrocephalus in mice fed the substituted hydrazine, cuprizone. , 1970, Experimental and molecular pathology.
[279] W. Carlton,et al. Spongiform encephalopathy induced in rats and guinea pigs by cuprizone. , 1969, Experimental and molecular pathology.
[280] Kinuko Suzuki. Giant Hepatic Mitochondria: Production in Mice Fed with Cuprizone , 1969, Science.
[281] W. Carlton,et al. Studies on the induction of hydrocephalus and spongy degeneration by cuprizone feeding and attempts to antidote the toxicity. , 1967, Life sciences.
[282] W. Carlton,et al. Response of mice to the chelating agents sodium diethyldithiocarbamate, alpha-benzoinoxime, and biscyclohexanone oxaldihydrazone. , 1966, Toxicology and applied pharmacology.
[283] G. D. De Beer. New insight into an old story , 1966 .
[284] P. Kinell,et al. A New Colour Reaction on Copper and Certain Carbonyl Compounds. , 1950 .